Stockreport

NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results [Yahoo! Finance]

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF CAMBRIDGE, Mass. June 24, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegener [Read more]